These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3948695)

  • 1. Monotherapy in institutionalized epileptics.
    Clark BG; Bledsoe MA; Lewis J; Thompson LL
    Drug Intell Clin Pharm; 1986 Feb; 20(2):156-7. PubMed ID: 3948695
    [No Abstract]   [Full Text] [Related]  

  • 2. A decade of modern epilepsy therapy in institutionalized mentally retarded patients.
    Pellock JM; Hunt PA
    Epilepsy Res; 1996 Nov; 25(3):263-8. PubMed ID: 8956925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diphenylhydantoin therapy on folate metabolism of mentally retarded epileptics.
    Arakawa T; Yoshida T; Honda Y; Narisawa K; Hirono H
    Tohoku J Exp Med; 1973 May; 110(1):59-68. PubMed ID: 4729235
    [No Abstract]   [Full Text] [Related]  

  • 4. Mono- or polypharmacotherapy in institutionalized epileptic children with severe mental retardation? A team approach for optimizing antiepileptic therapy.
    Ferngren H; Akerström I; Rane A
    Acta Paediatr Scand; 1991 Apr; 80(4):458-65. PubMed ID: 2058396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy.
    Carpay JA; Aalbers K; Graveland GA; Engelsman M
    Seizure; 2009 Mar; 18(2):119-23. PubMed ID: 18760635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic intervention in mentally retarded adult epileptics.
    Sivenius J; Savolainen S; Kaski M; Riekkinen PJ
    Acta Neurol Scand; 1990 Feb; 81(2):165-7. PubMed ID: 2327238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR; McKee JR; Hammer AE; Vuongc A
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of sulthiame with disturbed mentally subnormal patients.
    Moffatt WR; Siddiqui AR; MacKay DN
    Br J Psychiatry; 1970 Dec; 117(541):673-8. PubMed ID: 4395345
    [No Abstract]   [Full Text] [Related]  

  • 10. Seizure management with minimal medications in institutionalized mentally retarded epileptics. A prospective study. First report after 4 1/2 years of follow up.
    Alvarez N; Hazlett J
    Clin Electroencephalogr; 1983 Jul; 14(3):164-72. PubMed ID: 6616892
    [No Abstract]   [Full Text] [Related]  

  • 11. Salivary phenytoin levels in institutionalized epileptics.
    Hassell T; O'Donnell J; Pearlman J; Tesini D; Best H; Murphy T
    J Chronic Dis; 1983; 36(12):899-906. PubMed ID: 6655035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical guidelines for the management of epilepsy in adults with an intellectual disability.
    Working group of the International Association of the Scientific Study of Intellectual Disability
    Seizure; 2001 Sep; 10(6):401-9. PubMed ID: 11700992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
    Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
    Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability.
    Gaily E; Granström ML; Liukkonen E
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():41-5. PubMed ID: 10030431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing therapy of seizures in children and adolescents with developmental disabilities.
    Smith MC
    Neurology; 2006 Dec; 67(12 Suppl 4):S52-5. PubMed ID: 17190924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mysoline in the treatment of recalcitrant idiopathic major epilepsy in mentally defective children.
    COUSTON TA
    Arch Dis Child; 1954 Aug; 29(146):323-5. PubMed ID: 13189608
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term course of epilepsy in a large cohort of intellectually disabled patients.
    Huber B; Hauser I; Horstmann V; Jokeit G; Liem S; May T; Meinert T; Robertson E; Schorlemmer H; Wagner W; Seidel M
    Seizure; 2007 Jan; 16(1):35-42. PubMed ID: 17157535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The retention of lacosamide in patients with epilepsy and intellectual disability in three specialised institutions.
    Brenner J; Majoie HJM; van Beek S; Carpay JA
    Seizure; 2017 Nov; 52():123-130. PubMed ID: 29031193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-mannosidae deficiency in two mentally retarded girls with intractable seizures.
    Cherian MP
    Ann Saudi Med; 2004; 24(5):393-5. PubMed ID: 15573858
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of rationalizing drug treatment of patients with epilepsy and mental retardation.
    Beghi E; Bollini P; Di Mascio R; Cerisola N; Merloni T; Manghi E
    Dev Med Child Neurol; 1987 Jun; 29(3):363-9. PubMed ID: 3596072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.